Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Explore effective ways to make money and pay off debt. Boost your finances and achieve your goals with our actionable tips.
28,655 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Independence Day grilling costs rise to a new peak for a 10-person cookout, underscoring how inflation is shaping hol...
Rezervology and Titl unveil RezeLink, an AI-native platform designed to speed title searches for SoftPro users, boast...
In Q1 2026, the median price of a new single-family home slipped below the median price of an existing home for the f...
May 2026 data from the Federal Reserve show consumer credit contracted, ending a six-month gain. Analysts warn the pu...
The Department of Justice has released additional Epstein-related records that include unverified accusations about P...
With rates going higher, investors seek dependable income. This story highlights four dividend stocks across core sec...
AST SpaceMobile sits at a $29 billion valuation despite a modest quarterly revenue. A wave of dilution worries and a ...
Chevron stock has cooled from a $209 peak, leaving investors weighing dividend coverage, cash flow, and growth amid v...
The White House says the trip will be brief, while diplomats work toward a framework on Iran's nuclear program and re...
A large fund trimmed its DigitalBridge position, sparking questions about stake moves, stock momentum, and how invest...
Geopolitical conflicts are upending the classic playbook for U.S. stocks. The S&P 500 has not followed the traditiona...